An established biopharmaceutical company selected our EDC product for its important Phase 3 clinical trial.
If you would like to learn more about our products and services, please contact us at sales@fountayn.com.
Biopharmaceutical Company Selects Our EDC for Important Phase 3 Clinical Trial
DATATRAK International, Inc. on 6ix
Earlier from DATATRAK International
- eTMF Product Ready & Available for Demos!
- Earnings Announcement
- Officer/Director/Affiliate Stock Transactions
- Director Stock Transactions
- Datatrak Reports 2022 Earnings
Later from DATATRAK International
- Medical Implants Sponsor Selects Datatrak's EDC
- Therapeutic Sponsor Selects Datatrak's EDC
- Global CRO Selects Datatrak's Software Platform
- Annual Shareholder Meeting Results
- Global CRO Enters Into Enterprise Agreement with Datatrak
Follow DATATRAK International into a list and get an email when it puts out news.
Follow DATATRAK International